Actemium Supports Groundbreaking Medical Innovation with Orano Med’s ATEF Facility

Expertise at the Service of Advanced Medical Innovation

Actemium Projets Nucléaires France, specialist in managing complex electrical and physical protection projects within sensitive nuclear environments, has been selected for a key role in the construction of the Advanced Thorium Extraction Facility (ATEF). This milestone project, developed by Orano Med, represents a significant leap forward in targeted alpha therapy for oncology, marking the first-ever industrial installation dedicated to thorium-228 production. This rare isotope is a crucial precursor to lead-212, used in promising new approaches to cancer treatment.

Comprehensive Electrical and Process Control Solutions

Within this cutting-edge facility, Actemium Projets Nucléaires France is responsible for a wide array of critical tasks: from high-voltage power distribution to low-voltage systems, process instrumentation, control-command systems, radiological and nuclear process monitoring, and physical protection infrastructure. These complex and tightly regulated operations require the highest level of technical precision and nuclear safety expertise—an area where Actemium excels through decades of experience and innovation.

Proud Partnership for a Common Mission: Fighting Cancer

The teams at Actemium Projets Nucléaires France are honored to contribute to such a forward-thinking and life-saving initiative. Their involvement underscores Actemium’s capacity to support major industrial and medical breakthroughs through trusted technical leadership. Actemium warmly thanks Orano Med and Orano Projets for their confidence in awarding this ambitious contract. As one of the 27 entities within VINCI Energies’ Nuclear Division, Actemium Projets Nucléaires France continues to affirm its commitment to excellence in the nuclear sector and beyond.